42.45 USD
-0.6 (-1.39%)
42.8054 USD
+0.36 (+0.84%)
We assign a fundamental rating of 6 out of 10 to VCYT. VCYT was compared to 528 industry peers in the Biotechnology industry. VCYT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. VCYT is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes VCYT very considerable for growth investing!
1. Profitability
1.1 Basic Checks
- VCYT had positive earnings in the past year.
- In the past year VCYT had a positive cash flow from operations.
- In the past 5 years VCYT reported 4 times negative net income.
- The reported operating cash flow has been mixed in the past 5 years: VCYT reported negative operating cash flow in multiple years.
1.2 Ratios
- With an excellent Return On Assets value of 2.21%, VCYT belongs to the best of the industry, outperforming 89.20% of the companies in the same industry.
- VCYT has a better Return On Equity (2.40%) than 90.15% of its industry peers.
- VCYT has a Return On Invested Capital of 2.96%. This is amongst the best in the industry. VCYT outperforms 89.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.21% | ||
| ROE | 2.4% | ||
| ROIC | 2.96% |
ROA(3y)-2.65%
ROA(5y)-4.39%
ROE(3y)-2.82%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- VCYT has a Profit Margin of 6.10%. This is amongst the best in the industry. VCYT outperforms 89.96% of its industry peers.
- VCYT has a Operating Margin of 9.81%. This is amongst the best in the industry. VCYT outperforms 91.48% of its industry peers.
- The Gross Margin of VCYT (68.53%) is better than 81.06% of its industry peers.
- In the last couple of years the Gross Margin of VCYT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.81% | ||
| PM (TTM) | 6.1% | ||
| GM | 68.53% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
2. Health
2.1 Basic Checks
- VCYT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- VCYT has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, VCYT has more shares outstanding
- VCYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 18.94 indicates that VCYT is not in any danger for bankruptcy at the moment.
- VCYT's Altman-Z score of 18.94 is amongst the best of the industry. VCYT outperforms 88.07% of its industry peers.
- VCYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 18.94 |
ROIC/WACC0.34
WACC8.82%
2.3 Liquidity
- A Current Ratio of 6.24 indicates that VCYT has no problem at all paying its short term obligations.
- With a decent Current ratio value of 6.24, VCYT is doing good in the industry, outperforming 64.02% of the companies in the same industry.
- A Quick Ratio of 5.96 indicates that VCYT has no problem at all paying its short term obligations.
- VCYT has a Quick ratio of 5.96. This is in the better half of the industry: VCYT outperforms 63.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.24 | ||
| Quick Ratio | 5.96 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 353.33% over the past year.
- The Revenue has grown by 16.41% in the past year. This is quite good.
- Measured over the past years, VCYT shows a very strong growth in Revenue. The Revenue has been growing by 29.93% on average per year.
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
3.2 Future
- The Earnings Per Share is expected to grow by 51.21% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 11.52% on average over the next years. This is quite good.
EPS Next Y76.8%
EPS Next 2Y87.27%
EPS Next 3Y59.79%
EPS Next 5Y51.21%
Revenue Next Year14.5%
Revenue Next 2Y12.7%
Revenue Next 3Y12.38%
Revenue Next 5Y11.52%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 111.71 indicates a quite expensive valuation of VCYT.
- VCYT's Price/Earnings ratio is rather cheap when compared to the industry. VCYT is cheaper than 89.58% of the companies in the same industry.
- When comparing the Price/Earnings ratio of VCYT to the average of the S&P500 Index (27.33), we can say VCYT is valued expensively.
- Based on the Price/Forward Earnings ratio of 40.35, the valuation of VCYT can be described as expensive.
- 91.48% of the companies in the same industry are more expensive than VCYT, based on the Price/Forward Earnings ratio.
- VCYT is valuated expensively when we compare the Price/Forward Earnings ratio to 24.12, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 111.71 | ||
| Fwd PE | 40.35 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 91.67% of the companies listed in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 93.37% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.15 | ||
| EV/EBITDA | 42.32 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The decent profitability rating of VCYT may justify a higher PE ratio.
- VCYT's earnings are expected to grow with 59.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.45
PEG (5Y)N/A
EPS Next 2Y87.27%
EPS Next 3Y59.79%
5. Dividend
5.1 Amount
- VCYT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
42.45
-0.6 (-1.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-23 2026-02-23/amc
Inst Owners114.83%
Inst Owner Change-0.02%
Ins Owners0.42%
Ins Owner Change-3.94%
Market Cap3.36B
Revenue(TTM)495.14M
Net Income(TTM)30.18M
Analysts82.11
Price Target49.33 (16.21%)
Short Float %6.68%
Short Ratio5.63
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.65%
Min EPS beat(2)-110.32%
Max EPS beat(2)79.03%
EPS beat(4)2
Avg EPS beat(4)-1.91%
Min EPS beat(4)-110.32%
Max EPS beat(4)79.03%
EPS beat(8)5
Avg EPS beat(8)108.97%
EPS beat(12)8
Avg EPS beat(12)67.3%
EPS beat(16)12
Avg EPS beat(16)58.01%
Revenue beat(2)2
Avg Revenue beat(2)4.54%
Min Revenue beat(2)3.31%
Max Revenue beat(2)5.76%
Revenue beat(4)3
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)4.03%
Revenue beat(12)11
Avg Revenue beat(12)4.6%
Revenue beat(16)15
Avg Revenue beat(16)5.32%
PT rev (1m)0%
PT rev (3m)17.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.94%
EPS NY rev (1m)1.3%
EPS NY rev (3m)40.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.48%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)1.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 111.71 | ||
| Fwd PE | 40.35 | ||
| P/S | 6.78 | ||
| P/FCF | 34.15 | ||
| P/OCF | 31.07 | ||
| P/B | 2.67 | ||
| P/tB | 8.41 | ||
| EV/EBITDA | 42.32 |
EPS(TTM)0.38
EY0.9%
EPS(NY)1.05
Fwd EY2.48%
FCF(TTM)1.24
FCFY2.93%
OCF(TTM)1.37
OCFY3.22%
SpS6.26
BVpS15.91
TBVpS5.05
PEG (NY)1.45
PEG (5Y)N/A
Graham Number11.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.21% | ||
| ROE | 2.4% | ||
| ROCE | 3.75% | ||
| ROIC | 2.96% | ||
| ROICexc | 4.13% | ||
| ROICexgc | 54.36% | ||
| OM | 9.81% | ||
| PM (TTM) | 6.1% | ||
| GM | 68.53% | ||
| FCFM | 19.84% |
ROA(3y)-2.65%
ROA(5y)-4.39%
ROE(3y)-2.82%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
F-Score8
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 44.32% | ||
| Cap/Sales | 1.97% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 153.06% | ||
| Profit Quality | 325.55% | ||
| Current Ratio | 6.24 | ||
| Quick Ratio | 5.96 | ||
| Altman-Z | 18.94 |
F-Score8
WACC8.82%
ROIC/WACC0.34
Cap/Depr(3y)39.23%
Cap/Depr(5y)36.18%
Cap/Sales(3y)2.7%
Cap/Sales(5y)2.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
EPS Next Y76.8%
EPS Next 2Y87.27%
EPS Next 3Y59.79%
EPS Next 5Y51.21%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
Revenue Next Year14.5%
Revenue Next 2Y12.7%
Revenue Next 3Y12.38%
Revenue Next 5Y11.52%
EBIT growth 1Y433.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year319.96%
EBIT Next 3Y74.15%
EBIT Next 5Y48.27%
FCF growth 1Y237.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y181.1%
OCF growth 3YN/A
OCF growth 5YN/A
VERACYTE INC / VCYT FAQ
What is the fundamental rating for VCYT stock?
ChartMill assigns a fundamental rating of 6 / 10 to VCYT.
What is the valuation status of VERACYTE INC (VCYT) stock?
ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.
How profitable is VERACYTE INC (VCYT) stock?
VERACYTE INC (VCYT) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for VCYT stock?
The Price/Earnings (PE) ratio for VERACYTE INC (VCYT) is 111.71 and the Price/Book (PB) ratio is 2.67.
What is the financial health of VERACYTE INC (VCYT) stock?
The financial health rating of VERACYTE INC (VCYT) is 8 / 10.